Magnetic Resonance Imaging

22

Jun 2020

In the middle of May 2020, Västra Götaland HTA-Centre published an HTA on magnetic resonance image-guided radiotherapy in patients with cancer aiming to assess whether the studied method improves treatment results compared to current methods. It was concluded that the new technique might be associated with a higher proportion of treatment sessions reaching target coverage goals and a lower number of treatment sessions with violations of organs at risk constraints. However, the extent of improvement varied substantially between studies, and the certainty of the evidence is low. Read more

20

Nov 2019

The HTA center of Swedish Västra Götaland region is aimed to work for the continuous development of knowledge-based care in the region and ensure that healthcare is supported by science and evaluation. Currently, Västra Götaland HTA-Centre works on several HTA projects related to medical procedures or devices: alertness therapy, MRI linac, and investigation, and treatment of PANS / PANDAS. After completion of assessments, the final reports would be released on the website of Västra Götaland region. Read more

07

Mar 2019

In Norway, the mini-HTA for magnetic technology (Magseed) for breast lesions was released in February of 2018. The method was determined as efficient, safe and was recommended to be introduced as part of the clinical routine in the hospital. Read more

16

Jan 2019

The report presents a summary of reimbursement situation for Magnetic Resonance Imaging (MRI) in ambulatory settings. Both MRI with and without contrast are considered. All procedure codes will be provided in the analysis. When fee for service payment model is used, all fees for available reimbursement codes will be provided. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. Read more